Y Nishimura

745 total citations
29 papers, 602 citations indexed

About

Y Nishimura is a scholar working on Pulmonary and Respiratory Medicine, Hepatology and Epidemiology. According to data from OpenAlex, Y Nishimura has authored 29 papers receiving a total of 602 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 9 papers in Hepatology and 7 papers in Epidemiology. Recurrent topics in Y Nishimura's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease and Transplantation (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Y Nishimura is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease and Transplantation (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Y Nishimura collaborates with scholars based in Japan. Y Nishimura's co-authors include Hideo Uchida, K Nishimine, Tetsuya Yoshioka, Naoki Matsuo, Munehiro Maeda, Shigeo Saiwai, Teppei Komatsu, S Taniguchi, Yuichi Inoue and Tadaaki Miyamoto and has published in prestigious journals such as Scientific Reports, Radiology and British Journal of Cancer.

In The Last Decade

Y Nishimura

28 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Y Nishimura Japan 11 314 199 160 123 109 29 602
Luis F. Fajardo United States 8 388 1.2× 125 0.6× 237 1.5× 175 1.4× 266 2.4× 14 880
JT Chen Taiwan 14 129 0.4× 110 0.6× 161 1.0× 141 1.1× 50 0.5× 24 541
Páll Helgi Möller Iceland 17 119 0.4× 59 0.3× 184 1.1× 278 2.3× 79 0.7× 56 781
Hirotaka Arai Japan 16 560 1.8× 438 2.2× 109 0.7× 476 3.9× 28 0.3× 59 928
Shu‐Wen How Taiwan 10 157 0.5× 171 0.9× 74 0.5× 104 0.8× 57 0.5× 22 458
David W. C. Yeung Hong Kong 13 231 0.7× 122 0.6× 212 1.3× 157 1.3× 298 2.7× 21 835
Shoko Abe Japan 12 66 0.2× 62 0.3× 129 0.8× 186 1.5× 33 0.3× 34 470
Ken Watanabe Japan 13 225 0.7× 99 0.5× 69 0.4× 161 1.3× 51 0.5× 44 514
Serpil Dızbay Sak Türkiye 15 40 0.1× 85 0.4× 245 1.5× 184 1.5× 90 0.8× 92 775
Y. Okada Japan 14 50 0.2× 134 0.7× 125 0.8× 136 1.1× 159 1.5× 57 607

Countries citing papers authored by Y Nishimura

Since Specialization
Citations

This map shows the geographic impact of Y Nishimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Y Nishimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Y Nishimura more than expected).

Fields of papers citing papers by Y Nishimura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Y Nishimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Y Nishimura. The network helps show where Y Nishimura may publish in the future.

Co-authorship network of co-authors of Y Nishimura

This figure shows the co-authorship network connecting the top 25 collaborators of Y Nishimura. A scholar is included among the top collaborators of Y Nishimura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Y Nishimura. Y Nishimura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tateishi, Kosuke, Y Nishimura, Masayuki Sakuma, Fumio Yokohari, & Hidehiro Watanabe. (2020). Sensory neurons that respond to sex and aggregation pheromones in the nymphal cockroach. Scientific Reports. 10(1). 1995–1995. 4 indexed citations
2.
Ihara, Masafumi, et al.. (1999). [The significance of color duplex ultrasonography for the diagnosis of temporal arteritis].. PubMed. 39(10). 1001–5. 3 indexed citations
3.
Shibamoto, Yuta, Gakuji Ohshio, Ryo Hosotani, et al.. (1997). A phase I/II study of a hypoxic cell radiosensitizer KU-2285 in combination with intraoperative radiotherapy. British Journal of Cancer. 76(11). 1474–1479. 16 indexed citations
4.
Kokubo, Masayo, Y Nishimura, Y. Nagata, et al.. (1997). Dose-Volume Histogram Analysis of External-Beam Irradiation Combined with IORT for Unresectable Pancreatic Cancer. Frontiers of radiation therapy and oncology. 31. 177–180. 2 indexed citations
5.
Yamaguchi, Kazumi, et al.. (1995). [Clinical study on incidental renal cell carcinoma].. PubMed. 41(2). 93–9. 2 indexed citations
6.
Nishimine, K, Hideo Uchida, Naoki Matsuo, et al.. (1994). Segmental transarterial chemoembolization with lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results. Cancer Chemotherapy and Pharmacology. 33(S1). S60–S68. 56 indexed citations
7.
Nakao, Norio, et al.. (1994). Determination of the optimum dose level of lipiodol in transcatheter arterial embolization of primary hepatocellular carcinoma based on retrospective multivariate analysis. CardioVascular and Interventional Radiology. 17(2). 76–80. 15 indexed citations
8.
Matsuo, Naoki, Hideo Uchida, K Nishimine, et al.. (1993). Segmental Transcatheter Hepatic Artery Chemoembolization with Iodized Oil for Hepatocellular Carcinoma: Antitumor Effect and Influence on Normal Tissue. Journal of Vascular and Interventional Radiology. 4(4). 543–549. 53 indexed citations
9.
Uchida, Hideo, et al.. (1993). Transcatheter Arterial Embolization for Hepatoma with Lipiodol - Hepatic Arterial and Segmental Use. Seminars in Interventional Radiology. 10(1). 19–26. 12 indexed citations
10.
Komatsu, Hisateru, et al.. (1993). [Metastasis of hepatocellular carcinoma to the urinary bladder].. PubMed. 32(1). 64–5. 2 indexed citations
11.
Nakao, Norio, Hideo Uchida, Y Nishimura, et al.. (1992). Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemotherapy and Pharmacology. 31(S1). S72–S76. 16 indexed citations
12.
Matsuo, Naoki, K Nishimine, H Uchida, et al.. (1992). [Usefulness of segmental Lp-TAE using lipiodol mixed with anticancer agent for inoperable hepatocellular carcinoma].. PubMed. 89(7). 1415–24. 4 indexed citations
13.
Yamada, Naoaki, S Imakita, Y Nishimura, et al.. (1990). Evaluation of the susceptibility effect on the phase images of a simple gradient echo.. Radiology. 175(2). 561–565. 29 indexed citations
14.
Uchida, Hideo, Naoki Matsuo, K Nishimine, et al.. (1990). Transcatheter hepatic segmental arterial embolization using lipiodol mixed with an anticancer drug and gelfoam particles for hepatocellular carcinoma. CardioVascular and Interventional Radiology. 13(3). 140–145. 178 indexed citations
15.
Nakano, Toshiaki, et al.. (1990). [A case of secondary amyloidosis complicated with ulcerative colitis].. PubMed. 32(4). 435–9. 1 indexed citations
16.
Yoshimura, Hitoshi, H Sakaguchi, K Nishimine, et al.. (1989). Afterloading intracavitary irradiation and expanding stent for malignant biliary obstruction.. PubMed. 7(1). 36–41. 3 indexed citations
17.
Katsuragi, M, et al.. (1989). [A case of gall bladder cancer with high level alpha-fetoprotein].. PubMed. 34(3). 371–4. 2 indexed citations
18.
Nishimura, Y, Hitoshi Yoshimura, Keiji Iwata, et al.. (1989). [Distribution of pulsed intra arterial infusion chemotherapy in hepatic carcinomas].. PubMed. 16(8 Pt 2). 2991–4. 2 indexed citations
19.
Sakaguchi, H, Hitoshi Yoshimura, Takashi Tamada, et al.. (1988). [Development and clinical application of biliary endoprosthesis using expandable metallic stents].. PubMed. 48(9). 1183–5. 2 indexed citations
20.
Hayakawa, H., Akihiko Sato, Kazuho Honda, et al.. (1986). [A clinico-pathological study of allergic granulomatous angitis--on our experience of three cases and literature review of 56 cases reported in Japan].. PubMed. 75(8). 1075–84. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026